drugset / Trial / NCT02312934

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

NCT02312934

Phase 2 Completed 22 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the use of a nicotine patch as a treatment for problems with attention, learning and memory in breast cancer patients who are 1-5 years post chemotherapy.

Timeline

Start
2015-08
Primary completion
2018-05
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 14 mg Other